Found 6 matching trials
Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery PHASE4 Limited/poor weight loss and weight regain are concerns following bariatric...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) PHASE4 In the Netherlands, there are many people with cardiometabolic diseases. Mo...
Show More Status
Enrolling By Invitation
Learn More & Join Trial
Real-World Evidence on the Cardiovascular Safety of CONTRAVE® in the United States (U.S.) N/A The fixed-dose combination of naltrexone 8mg and bupropion 90mg extended-re...
Show More Location
Currax Pharmaceuticals
Learn More & Join Trial
Drug Utilisation of Mysimba/Contrave N/A This study will assess a retrospective cohort of users of Mysimba/Contrave ...
Show More Location
Currax Pharmaceuticals
Learn More & Join Trial
Use of Mysimba in Patients With Weight Regain After Bariatric Surgery PHASE4 Although bariatric surgery is currently the most effective treatment for mo...
Show More Location
Zuyderland Medical Center
Learn More & Join Trial
Effect of Naltrexone Hydrochloride ER and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on Major Adverse Cardiovascular Events (MACE) PHASE4 A randomized, double-blinded, placebo controlled study intended to capture ...
Show More Status
Active Not Recruiting
Location
TrialMed Birmingham (DRS)
Learn More & Join Trial